Phoebe Dunn

CEO at mRNA Victoria

Speaker

As Chief Executive Officer of mRNA Victoria since January 2024, and previously Chief Investment Officer from March 2022, Phoebe Dunn brings over two decades of public sector expertise to establishing Victoria as a leading mRNA biotechnology hub.

With extensive experience across public, private, and community sectors, Phoebe specialises in strategic coordination between government, research institutions, and industry to drive policy outcomes and economic impact.

Her background in designing and delivering major policy reforms and commercial projects directly equips her to lead the growth of the mRNA ecosystem in Victoria, from research and development to translation and commercialisation. She is passionate about advancing medical innovation to improve global health outcomes.